
Document Security System Shows Decrease in COVID-19 Viral Population Using 3F Biofragrance
Document Security Systems, Inc. has announced the study related tothe COVID-19 viral population.
FREMONT, CA: Document Security Systems, Inc. is a multinational organization operating a business. It focuses on technologies related to brand protection, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets. In recent times, the company has announced its wholly-owned subsidiary Impact BioMedical, Inc., with the help of its subsidiary Global BioLife, Inc., completed the efficiency testing of its patented 3F Antiviral Biofragrance at a biosafety level 3 containment facility at an independent university. Furthermore, the study explains about a 10-fold reduction in COVID-19 viral population on surfaces using 3F Biofragrance.
According to Daryl Thompson, Global BioLife's Director of Scientific Initiatives and founder of advanced research company GRDG Sciences, LLC ("GRDG"), "We are extremely excited with the results of the study, which was based on a quantifiable, robust model and designed to treat high levels of the COVID-19 virus.As the world continues to battle COVID-19, common antimicrobial compounds have the potential to be overused, leading to new health concerns. We designed 3F Biofragrance to solve this issue through a multi-focal approach to inhibiting viruses that reduces the chances of developing resistance as seen with other antimicrobials."
3F Biofragrance has been designed for the Open Air Defense Initiative. It was a strategy that can protect locations where vast numbers of people gather or transit like airports, containment areas, train stations, convention centers, hospitals, and ports of entry. Open Air Defense Initiative was developed as a solution for Event 201. The Johns Hopkins Center for Health Security, the World Economic Forum, and the Bill and Melinda Gates Foundation conducted this pandemic exercise in 2019. Event 201 emphasized the areas where it is necessary for the public or private partnerships so that they can respond to a severe pandemic. Other than COVID-19, 3F Biofragrance is also operative against E. coli, MRSA, Influenza, Rhinovirus, and Tuberculosis.
Thompson further stated, "3F Biofragrance has the potential to transform typical consumer products into weapons against the spread of COVID-19 and other viruses, and we look forward to providing updates on ongoing negotiations for global licensing and royalty agreements of this innovative technology."
Featured Vendors
Tenthpin: The Trusted Advisor for Data-Driven Patient- Centric Value Chain Management in Life Sciences
Process Stream: Into the Depths: How Process Stream Leverages Experience and Embedded Research to Transform Businesses from the Inside Out
Indegene: Leveraging Technology to Drive Growth and Productivity Investing In Innovation In Operations, Analytics and Clinical Technology
MMIS: Global Compliance Platform Streamlines Processes and Delivers Business Intelligence Enterprise-Wide
Acceliant: Leading with Innovation, Facilitating Collaboration, Standardization and Productivity in Clinical Trial Management
Saama Technologies: New Fluid Analytics Engine from Saama Cost-Effectively and Rapidly Resolves Complex Data Analytics Challenges for Life Sciences
Iris Interactive Corporation: Boosting Collaboration and Decision Making Processes to Bring Products
Techsol Corporation: Offering Domain Rich, Regulatory Compliant, Accelerated and Cloud Enabled Techn
Solea Software Solutions: Offering Business Intelligence, Analytics, and Portal Services for Flouris
Xybion Corporation: Providing Interconnected Technology Enabled Solutions for Life Sciences, and oth
EDITOR'S PICK
Essential Technology Elements Necessary To Enable...
By Leni Kaufman, VP & CIO, Newport News Shipbuilding
Comparative Data Among Physician Peers
By George Evans, CIO, Singing River Health System
Monitoring Technologies Without Human Intervention
By John Kamin, EVP and CIO, Old National Bancorp
Unlocking the Value of Connected Cars
By Elliot Garbus, VP-IoT Solutions Group & GM-Automotive...
Digital Innovation Giving Rise to New Capabilities
By Gregory Morrison, SVP & CIO, Cox Enterprises
Staying Connected to Organizational Priorities is Vital...
By Alberto Ruocco, CIO, American Electric Power
Comprehensible Distribution of Training and Information...
By Sam Lamonica, CIO & VP Information Systems, Rosendin...
The Current Focus is On Comprehensive Solutions
By Sergey Cherkasov, CIO, PhosAgro
Big Data Analytics and Its Impact on the Supply Chain
By Pascal Becotte, MD-Global Supply Chain Practice for the...
Technology's Impact on Field Services
By Stephen Caulfield, Executive Director, Global Field...
Carmax, the Automobile Business with IT at the Core
By Shamim Mohammad, SVP & CIO, CarMax
The CIO's role in rethinking the scope of EPM for...
By Ronald Seymore, Managing Director, Enterprise Performance...
Driving Insurance Agent Productivity with Mobile and Big...
By Brad Bodell, SVP and CIO, CNO Financial Group, Inc.
Transformative Impact On The IT Landscape
By Jim Whitehurst, CEO, Red Hat
Get Ready for an IT Renaissance: Brought to You by Big...
By Clark Golestani, EVP and CIO, Merck
Four Initiatives Driving ECM Innovation
By Scott Craig, Vice President of Product Marketing, Lexmark...
Technology to Leverage and Enable
By Dave Kipe, SVP, Global Operations, Scholastic Inc.
By Meerah Rajavel, CIO, Forcepoint
AI is the New UI-AI + UX + DesignOps
By Amit Bahree, Executive, Global Technology and Innovation,...
Evolving Role of the CIO - Enabling Business Execution...
By Greg Tacchetti, CIO, State Auto Insurance
Read Also
